| All (n=2449) | Male (n=1309) | Female (n=1121) | |||
---|---|---|---|---|---|---|
n (%) | 95% CI | n (%) | 95% CI | n (%) | 95% CI | |
PHQ-9 | ||||||
 None (0-4) | 1602 (65.4%) | 63.5-67.3% | 904 (69.1%) | 66.5-71.6% | 682 (60.8%) | 57.9-63.7% |
 Mild (5-9) | 564 (23.0%) | 21.3-24.8% | 258 (20.0%) | 17.6-22.0% | 304 (27.1%) | 24.5-29.8% |
 Moderate (10-14) | 191 (7.8%) | 6.8-8.9% | 98 (7.5%) | 6.1-9.1% | 93 (8.3%) | 6.8-10.1% |
 Moderately severe (15-19) | 57 (2.3%) | 1.8-3.0% | 30 (2.3%) | 1.6-3.3% | 26 (2.3%) | 1.5-3.4% |
 Severe (≥20) | 35 (1.4%) | 1.0-2.0% | 19 (1.5%) | 0.9-2.3% | 16 (1.4%) | 0.8-2.3% |
 Moderate~severe (10−) | 283 (11.6%) | 10.3-12.9% | 147 (11.2%) | 9.6-13.1% | 135 (12.0%) | 10.2-14.1% |
 Suicide-related ideation | 162 (6.7%) | 5.7-7.7% | 88 (6.7%) | 5.4-8.2% | 73 (6.6%) | 5.2-8.2% |
 Severe suicide-related ideation | 45 (1.9%) | 1.4-2.5% | 21 (1.6%) | 1.0-2.5% | 24 (2.2%) | 1.4-3.2% |